TALLAHASSEE, Fla. - A Florida federal judge on Oct. 15 denied a motion for summary judgment in a generic Adderall case, finding that a U.S. Supreme Court ruling allowing brand-name drug makers to strengthen drug warning labels fully applies to generic manufacturers (Jane R. Munroe, et al. v. Barr Laboratories, Inc., No. 07-395, N.D. Fla., Tallahassee Div.). From Mealey's Emerging Drugs & Devices